Pharmaceutical Compositions Comprising Nilotinib Or Its Salt

Patent No. EP2068839 (titled "Pharmaceutical Compositions Comprising Nilotinib Or Its Salt") was filed by Novartis on Sep 25, 2007. The application was issued on Oct 12, 2022.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2068839

NOVARTIS
Application Number
EP07820560A
Filing Date
Sep 25, 2007
Status
Patent Maintained As Amended
Sep 9, 2022
Publication Date
Oct 12, 2022